Title:
FUSION PROTEIN COMPOSITION(S) COMPRISING MASKED TYPE I INTERFERONS (IFNα AND IFNβ) FOR USE IN THE TREATMENT OF CANCER AND METHODS THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/265679
Kind Code:
A9
Abstract:
Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.
More Like This:
| WO/2014/003688 | A SURGICAL CUTTING BLADE |
| JP2008507996 | Systems and methods for treating a patient's lungs with induced radiation therapy or surgery |
| JP2021502227 | Safety surgical scalpel |
Inventors:
STOVER DAVID (US)
MORRISON SHERIE (US)
VASUTHASAWAT ALEX (US)
TRIHN KHAM (US)
MORRISON SHERIE (US)
VASUTHASAWAT ALEX (US)
TRIHN KHAM (US)
Application Number:
PCT/US2022/000011
Publication Date:
May 19, 2023
Filing Date:
June 17, 2022
Export Citation:
Assignee:
NAMMI THERAPEUTICS INC (US)
International Classes:
A61B17/3211; A61B90/00; B26B3/00
Attorney, Agent or Firm:
POPP, Shane, M. (US)
Download PDF: